Table: RaQualia Pharma - 9-MTH group results

RaQualia Pharma

09/11/2018 06:15

Nov 9 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2018        Sep 30, 2017      Dec 31, 2018  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            532 mln             606 mln            1.03      
                 (-12.1 pct)                           (-27.6 pct)  
  Operating     loss 835 mln        loss 554 mln        loss 1.02   
  Recurring     loss 818 mln        loss 487 mln      loss 996 mln  
  Net           loss 844 mln        loss 463 mln        loss 1.02   
  EPS          loss 41.47 yen      loss 24.16 yen    loss 50.31 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T